IHE · iShares

iShares U.S. Pharmaceuticals ETF

See how 60 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.

Holdings dated 21 August 2026Price US$98.65 as of 2 October 2026Coverage limitations apply

Core valuation

Trailing P/E71.54×100.00% coverage
Latest-quarter run-rate P/E61.69×100.00% coverage
Trailing P/S4.34×95.05% coverage
Latest-quarter run-rate P/S4.12×94.59% coverage

Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.00% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.

Largest reported holdings

Largest reported ETF holdings with weights and trailing valuation ratios
HoldingWeightTrailing P/ETrailing P/S
JNJJOHNSON & JOHNSON22.13%29.63×6.37×
LLYELI LILLY21.57%40.52×13.59×
MRKMERCK & CO INC5.00%111.82×5.33×
BMYBRISTOL MYERS SQUIBB4.71%13.53×2.55×
RPRXROYALTY PHARMA PLC CLASS A4.39%39.52×12.66×
PFEPFIZER4.28%36.99×2.52×
VTRSVIATRIS4.02%-48.83×1.36×
ZTSZOETIS INC CLASS A3.73%10.83×3.00×
JAZZJAZZ PHARMACEUTICALS PLC3.37%16.08×3.29×
ELANELANCO ANIMAL HEALTH2.53%-54.66×2.17×

Top 10 of 60 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.

Most similar funds

Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.

  1. PPH · VanEck Pharmaceutical ETF44.53% holdings overlap · Nasdaq
  2. XPH · State Street SPDR S&P Pharmaceuticals ETF38.77% holdings overlap · NYSE Arca
  3. FTXH · First Trust Nasdaq Pharmaceuticals ETF38.40% holdings overlap · Nasdaq
  4. IYH · iShares U.S. Healthcare ETF37.02% holdings overlap · US market
  5. XLV · State Street Health Care Select Sector SPDR ETF36.87% holdings overlap · US market

Sources and limitations

Holdings are sourced from iShares and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.

Open official holdings source

Research holdings date: 21 August 2026. Informational research, not investment advice.